APP and Alzheimer disease: It is known that amyloid-beta (Aβ) (1−40/42) peptides, generated by the cleavage of the amyloid precursor protein (APP) via the amyloidogenic pathway, are linked to the pathology of greater than 20 devastating human diseases including AD and other neurodegenerative disorders [14,15,16,17].